Related Experiment Video

Updated: May 28, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Clinical characteristics of G6PD deficiency in infants with marked hyperbilirubinemia

Yi-Hao Weng1, Ya-Wen Chiu

  • 1Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan. yihaoweng@adm.cgmh.org.tw

Journal of Pediatric Hematology/Oncology
|January 7, 2010
PubMed

Insights

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a significant risk factor for severe hyperbilirubinemia in infants. This condition increases the likelihood of mortality and kernicterus, highlighting the need for early detection.

Area of Science:

  • Neonatal Medicine
  • Pediatric Hematology
  • Genetic Disorders

Background:

  • Infants with marked hyperbilirubinemia require careful evaluation for underlying causes.
  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common inherited enzyme defect that can lead to hemolytic anemia.

Purpose of the Study:

  • To analyze the clinical features of G6PD deficiency in infants presenting with significant hyperbilirubinemia.
  • To determine the association between G6PD deficiency and the severity of hyperbilirubinemia, mortality, and neurological outcomes.

Main Methods:

  • Retrospective cohort study of 413 infants with peak total serum bilirubin (TSB) >or=20 mg/dL.
  • Data collected from 1995 to 2007, analyzing G6PD deficiency prevalence, clinical characteristics, and outcomes.

Main Results:

  • G6PD deficiency prevalence increased with TSB levels, reaching 100% in infants with TSB >or=40 mg/dL.
  • G6PD-deficient infants were more likely to have extreme hyperbilirubinemia (TSB >or=25 mg/dL) and lower hemoglobin levels.
  • Mortality was significantly higher in G6PD-deficient infants (3.0%) compared to G6PD-normal infants (0.0%).
  • Kernicterus occurred in 6.6% of followed G6PD-deficient infants.

Conclusions:

  • G6PD deficiency is a critical risk factor for severe hyperbilirubinemia in infants.
  • The study underscores the importance of screening for G6PD deficiency in jaundiced newborns.
  • Early identification and management of G6PD deficiency can potentially prevent severe complications like kernicterus and reduce infant mortality.
Abstract

More Related Videos

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...